The latest trend in treating hair loss may sound familiar — essentially, it's a repurposed drug first popularized in the ...

Cube will underpin many of the AI tools we will develop in the years to come, including highly complex scene-generation tools ...

Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) shares shot up 2.1% during trading on Wednesday after Bank of America raised their price target on the stock from $21.00 to $22.00. Bank of ...

While swiping left and right have become synonymous with dating culture among younger generations, a 2025 Hims study found ...

Hims & Hers Health is a top growth stock with strong cash flow, no debt, and an innovative AI-powered platform. Learn more on ...

Hims & Hers is shifting towards personalized medicine with AI-backed solutions. Find out why HIMS stock is buyable despite ...

The FDA wants bulk production of copycat versions of popular weight-loss drugs to stop, but telehealth companies and compounding pharmacies ...

The FDA wants to end bulk production of copycat versions of weight loss drugs; telehealth companies and compounding ...

According to a study by Hims in 2025, the majority of people in the U.S. still prefer meeting their partners in person rather than through digital means. Despite the popularity of online dating apps, ...

Shares of Hims & Hers rose 7.59 percent on Wednesday to finish at $33.88 apiece as investors resorted to bargain-hunting ...

Healthcare companies were flat as traders rotated into higher-risk sectors. Shares of Hims & Hers rallied after the online pharmacy said it would continue selling compounded versions of glucagon-like ...